Neuberger Berman Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
MPI
Neuberger Berman Group's CLB Position: Q1 2020 in Review
Neuberger Berman Group sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 250,037 shares — an estimated $9.56M sold.
Neuberger Berman Group first reported a position in CLB in Q2 2013 and held it in 16 quarters. The position peaked at $63M in Q3 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.
- Neuberger Berman Group reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
- Neuberger Berman Group sold 250,037 Core Laboratories shares in Q1 2020, an estimated $9.56M.
- Neuberger Berman Group first reported a position in Core Laboratories in Q2 2013 and held it in 16 quarters.
- Neuberger Berman Group's Core Laboratories position peaked at $63M in Q3 2018.
- 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.
Based on Neuberger Berman Group's 13F filing for Q1 2020, filed 14 May 2020.